OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients
Tarec Christoffer El‐Galaly, Martin Bjerregård Pedersen, Martin Hutchings, et al.
American Journal of Hematology (2015) Vol. 90, Iss. 11, pp. 975-980
Open Access | Times Cited: 54
Tarec Christoffer El‐Galaly, Martin Bjerregård Pedersen, Martin Hutchings, et al.
American Journal of Hematology (2015) Vol. 90, Iss. 11, pp. 975-980
Open Access | Times Cited: 54
Showing 1-25 of 54 citing articles:
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
Sally F. Barrington, Regine Kluge
European Journal of Nuclear Medicine and Molecular Imaging (2017) Vol. 44, Iss. S1, pp. 97-110
Open Access | Times Cited: 241
Sally F. Barrington, Regine Kluge
European Journal of Nuclear Medicine and Molecular Imaging (2017) Vol. 44, Iss. S1, pp. 97-110
Open Access | Times Cited: 241
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Steven M. Horwitz, Stephen M. Ansell, Weiyun Z. Ai, et al.
Journal of the National Comprehensive Cancer Network (2022) Vol. 20, Iss. 3, pp. 285-308
Open Access | Times Cited: 116
Steven M. Horwitz, Stephen M. Ansell, Weiyun Z. Ai, et al.
Journal of the National Comprehensive Cancer Network (2022) Vol. 20, Iss. 3, pp. 285-308
Open Access | Times Cited: 116
Tarec Christoffer El‐Galaly, Diego Villa, Lars Christian Gormsen, et al.
Journal of Internal Medicine (2018) Vol. 284, Iss. 4, pp. 358-376
Open Access | Times Cited: 112
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)
Anne‐Ségolène Cottereau, Stéphanie Becker, Florence Broussais, et al.
Annals of Oncology (2016) Vol. 27, Iss. 4, pp. 719-724
Open Access | Times Cited: 100
Anne‐Ségolène Cottereau, Stéphanie Becker, Florence Broussais, et al.
Annals of Oncology (2016) Vol. 27, Iss. 4, pp. 719-724
Open Access | Times Cited: 100
Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis
Baoping Guo, Xiaohong Tan, Qing Ke, et al.
PLoS ONE (2019) Vol. 14, Iss. 1, pp. e0210224-e0210224
Open Access | Times Cited: 97
Baoping Guo, Xiaohong Tan, Qing Ke, et al.
PLoS ONE (2019) Vol. 14, Iss. 1, pp. e0210224-e0210224
Open Access | Times Cited: 97
Peripheral T-cell lymphoma, not otherwise specified
Alessandro Broccoli, Pier Luigi Zinzani
Blood (2017) Vol. 129, Iss. 9, pp. 1103-1112
Closed Access | Times Cited: 97
Alessandro Broccoli, Pier Luigi Zinzani
Blood (2017) Vol. 129, Iss. 9, pp. 1103-1112
Closed Access | Times Cited: 97
The Danish National Lymphoma Registry: Coverage and Data Quality
Bente Arboe, Tarec Christoffer El‐Galaly, Michael Roost Clausen, et al.
PLoS ONE (2016) Vol. 11, Iss. 6, pp. e0157999-e0157999
Open Access | Times Cited: 93
Bente Arboe, Tarec Christoffer El‐Galaly, Michael Roost Clausen, et al.
PLoS ONE (2016) Vol. 11, Iss. 6, pp. e0157999-e0157999
Open Access | Times Cited: 93
PET/CT in Non-Hodgkin Lymphoma: An Update
Lucia Zanoni, Davide Bezzi, Cristina Nanni, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 320-351
Closed Access | Times Cited: 42
Lucia Zanoni, Davide Bezzi, Cristina Nanni, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 320-351
Closed Access | Times Cited: 42
The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma
Sally F. Barrington, Judith Trotman
The Lancet Haematology (2020) Vol. 8, Iss. 1, pp. e80-e93
Closed Access | Times Cited: 55
Sally F. Barrington, Judith Trotman
The Lancet Haematology (2020) Vol. 8, Iss. 1, pp. e80-e93
Closed Access | Times Cited: 55
PET/CT for Staging; Past, Present, and Future
Tarec Christoffer El‐Galaly, Lars Christian Gormsen, Martin Hutchings
Seminars in Nuclear Medicine (2017) Vol. 48, Iss. 1, pp. 4-16
Closed Access | Times Cited: 60
Tarec Christoffer El‐Galaly, Lars Christian Gormsen, Martin Hutchings
Seminars in Nuclear Medicine (2017) Vol. 48, Iss. 1, pp. 4-16
Closed Access | Times Cited: 60
Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients
Anne‐Ségolène Cottereau, Tarec Christoffer El‐Galaly, Stéphanie Becker, et al.
Journal of Nuclear Medicine (2017) Vol. 59, Iss. 4, pp. 589-595
Open Access | Times Cited: 52
Anne‐Ségolène Cottereau, Tarec Christoffer El‐Galaly, Stéphanie Becker, et al.
Journal of Nuclear Medicine (2017) Vol. 59, Iss. 4, pp. 589-595
Open Access | Times Cited: 52
The new biology of PTCL‐NOS and AITL: current status and future clinical impact
Matthew A. Timmins, Simon D. Wagner, Matthew J. Ahearne
British Journal of Haematology (2020) Vol. 189, Iss. 1, pp. 54-66
Open Access | Times Cited: 46
Matthew A. Timmins, Simon D. Wagner, Matthew J. Ahearne
British Journal of Haematology (2020) Vol. 189, Iss. 1, pp. 54-66
Open Access | Times Cited: 46
Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma
Neha Mehta‐Shah, Kimiteru Ito, Kurt S. Bantilan, et al.
Blood Advances (2019) Vol. 3, Iss. 2, pp. 187-197
Open Access | Times Cited: 42
Neha Mehta‐Shah, Kimiteru Ito, Kurt S. Bantilan, et al.
Blood Advances (2019) Vol. 3, Iss. 2, pp. 187-197
Open Access | Times Cited: 42
Magnetic Resonance Imaging and [18F ]‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography‐Guided Therapy Improves Survival in Upper Aerodigestive Tract NK /T‐Cell Lymphoma, Nasal Type: A Prospective Cohort Study
Quanguang Ren, Yue Cui, He Huang, et al.
Head & Neck (2025)
Closed Access
Quanguang Ren, Yue Cui, He Huang, et al.
Head & Neck (2025)
Closed Access
Interim FDG-PET Imaging in Lymphoma
Andrea Gallamini, C. Zwarthoed
Seminars in Nuclear Medicine (2017) Vol. 48, Iss. 1, pp. 17-27
Closed Access | Times Cited: 29
Andrea Gallamini, C. Zwarthoed
Seminars in Nuclear Medicine (2017) Vol. 48, Iss. 1, pp. 17-27
Closed Access | Times Cited: 29
FDG PET for Evaluation of Bone Marrow Status in T-Cell Lymphoma
Youngil Koh, Jung Min Lee, Go-Un Woo, et al.
Clinical Nuclear Medicine (2018) Vol. 44, Iss. 1, pp. 4-10
Closed Access | Times Cited: 24
Youngil Koh, Jung Min Lee, Go-Un Woo, et al.
Clinical Nuclear Medicine (2018) Vol. 44, Iss. 1, pp. 4-10
Closed Access | Times Cited: 24
Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial
Christine Hanoun, Jan Rekowski, Stefan Müller, et al.
Hematological Oncology (2020) Vol. 38, Iss. 3, pp. 244-256
Open Access | Times Cited: 22
Christine Hanoun, Jan Rekowski, Stefan Müller, et al.
Hematological Oncology (2020) Vol. 38, Iss. 3, pp. 244-256
Open Access | Times Cited: 22
Interim FDG-PET/CT for Response Assessment of Lymphoma
Merissa N. Zeman, Esma A. Akin, Reid W. Merryman, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 371-388
Closed Access | Times Cited: 13
Merissa N. Zeman, Esma A. Akin, Reid W. Merryman, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 371-388
Closed Access | Times Cited: 13
Angioimmunoblastic T-Cell Lymphoma
Alessandro Broccoli, Pier Luigi Zinzani
Hematology/Oncology Clinics of North America (2017) Vol. 31, Iss. 2, pp. 223-238
Closed Access | Times Cited: 19
Alessandro Broccoli, Pier Luigi Zinzani
Hematology/Oncology Clinics of North America (2017) Vol. 31, Iss. 2, pp. 223-238
Closed Access | Times Cited: 19
Treatment approaches in relapsed or refractory peripheral T-cell lymphomas
Cheryl J. Foster, John Kuruvilla
F1000Research (2020) Vol. 9, pp. 1091-1091
Open Access | Times Cited: 16
Cheryl J. Foster, John Kuruvilla
F1000Research (2020) Vol. 9, pp. 1091-1091
Open Access | Times Cited: 16
18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine–Rituximab
Dominick Lamonica, Daniel A. Graf, Mihaela Munteanu, et al.
Journal of Nuclear Medicine (2016) Vol. 58, Iss. 1, pp. 62-68
Open Access | Times Cited: 17
Dominick Lamonica, Daniel A. Graf, Mihaela Munteanu, et al.
Journal of Nuclear Medicine (2016) Vol. 58, Iss. 1, pp. 62-68
Open Access | Times Cited: 17
Outcome of limited‐stage peripheral T‐Cell lymphoma after CHOP (−like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group
Ahmed Ludvigsen Al‐Mashhadi
American Journal of Hematology (2023)
Closed Access | Times Cited: 5
Ahmed Ludvigsen Al‐Mashhadi
American Journal of Hematology (2023)
Closed Access | Times Cited: 5
Utility of PET-CT for Evaluation of Patients With Peripheral T-cell Lymphoma
Ronit Gurion, Hanna Bernstine, Liran Domachevsky, et al.
Clinical Lymphoma Myeloma & Leukemia (2018) Vol. 18, Iss. 10, pp. 687-691
Closed Access | Times Cited: 15
Ronit Gurion, Hanna Bernstine, Liran Domachevsky, et al.
Clinical Lymphoma Myeloma & Leukemia (2018) Vol. 18, Iss. 10, pp. 687-691
Closed Access | Times Cited: 15
The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma
Jun-Sang Ham, Sung Joon Kim, Joon Young Choi, et al.
Blood Cancer Journal (2016) Vol. 6, Iss. 2, pp. e395-e395
Open Access | Times Cited: 11
Jun-Sang Ham, Sung Joon Kim, Joon Young Choi, et al.
Blood Cancer Journal (2016) Vol. 6, Iss. 2, pp. e395-e395
Open Access | Times Cited: 11
Accuracy of 18-F FDG PET/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma – tissue remains the issue
Anthony Q. Pham, Stephen M. Broski, Thomas M. Habermann, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2017) Vol. 58, Iss. 10, pp. 2342-2348
Closed Access | Times Cited: 11
Anthony Q. Pham, Stephen M. Broski, Thomas M. Habermann, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2017) Vol. 58, Iss. 10, pp. 2342-2348
Closed Access | Times Cited: 11
